Related references
Note: Only part of the references are listed.MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
MIR-137 Suppresses Growth and Invasion, is Downregulated in Oligodendroglial Tumors and Targets CSE1L
Kay Ka-Wai Li et al.
BRAIN PATHOLOGY (2013)
Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients
Zhenyu Wu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion
Heidi G. Moller et al.
MOLECULAR NEUROBIOLOGY (2013)
Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme
Gang Li et al.
PLOS ONE (2013)
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
Ariel Bier et al.
ONCOTARGET (2013)
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea et al.
CANCER AND METASTASIS REVIEWS (2012)
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2
Lingchao Chen et al.
EUROPEAN JOURNAL OF CANCER (2012)
CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma
You-ke Xie et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells
Huanyu Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Context-specific microRNA analysis: identification of functional microRNAs and their mRNA targets
Noa Bossel Ben-Moshe et al.
NUCLEIC ACIDS RESEARCH (2012)
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
F. Orzan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion
Liping Liu et al.
CANCER RESEARCH (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
Z. L. Wu et al.
CELL DEATH AND DIFFERENTIATION (2010)
Cross talk between microRNA and epigenetic regulation in adult neurogenesis
Keith E. Szulwach et al.
JOURNAL OF CELL BIOLOGY (2010)
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
Michiel Smits et al.
ONCOTARGET (2010)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
Joachim Silber et al.
BMC MEDICINE (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
EZH2 promotes proliferation and invasiveness of prostate cancer cells
R. J. Bryant et al.
PROSTATE (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
